HANSA BIOPHARMA
Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverages its unique enzyme technology.
HANSA BIOPHARMA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2007-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.hansabiopharma.com
Total Employee:
51+
Status:
Active
Contact:
46 46 16 56 70
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Nginx Microsoft Exchange Online
Similar Organizations
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Current Employees Featured
Founder
Stock Details
Investors List
Novaquest Capital Management
Novaquest Capital Management investment in Grant - Hansa Biopharma
Official Site Inspections
http://www.hansabiopharma.com Semrush global rank: 4.08 M Semrush visits lastest month: 3 K
- Host name: 52.174.176.76
- IP address: 52.174.176.76
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Hansa Biopharma"
About Hansa Biopharma
Our values. At Hansa Biopharma, we strive to create an inclusive environment that embraces difference and fosters inclusion. We believe that valuing diversity and inclusion will create an environment in which all talent can grow and our โฆSee details»
Hansa Biopharma - Crunchbase Company Profile & Funding
Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases. They concentrate on creating novel, life โฆSee details»
Hansa Biopharma publishes 2023 Annual and Sustainability Reports
Lund, Sweden, March 21, 2024. Hansa Biopharma AB, โHansaโ or the โCompanyโ (Nasdaq Stockholm: HNSA), today announced the publication of its 2023 Annual and Sustainability โฆSee details»
Hansa Biopharma - Overview, News & Similar companies - ZoomInfo
Hansa Biopharma contact info: Phone number: (312) 386-8200 Website: www.hansabiopharma.com What does Hansa Biopharma do? Founded in 2007, Hansa โฆSee details»
Hansa Biopharma AB | VentureRadar
Similar Companies: Hansa Medical AB Sweden n/a Hansa Biopharma AB (NASDAQ Stockholm:HNSA) is harnessing its proprietary immunomodulatory enzyme technology โฆSee details»
Hansa Biopharma - Craft
Oct 29, 2024 Hansa Biopharma has 5 employees at their 1 location and kr134.09 m in annual revenue in FY 2023. See insights on Hansa Biopharma including office locations, competitors, โฆSee details»
Hansa Biopharma AB Company Description - Stock Analysis
Nov 12, 2024 Company profile for Hansa Biopharma AB (publ) (STO: HNSA) with a description, list of executives, contact details and other key facts.See details»
Hansa Biopharma plans restructuring to strengthen long-term ...
Dec 5, 2023 E: [email protected] About Hansa Biopharma Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a mission to โฆSee details»
Hansa Biopharma : Genethon and Hansa Biopharma
3 days ago The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the โฆSee details»
People - Hansa Biopharma
Hansa Biopharma and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics โฆSee details»
Hansa Biopharma AB: Genethon and Hansa Biopharma announce โฆ
3 days ago Stephanie Kenney, VP Global Corporate Affairs [email protected] GENETHON Stéphanie Bardon [email protected] +33 (0) 6.45.15.95.87 Notes to โฆSee details»
Hansa Biopharma publishes Annual Report 2022
Lund, Sweden, March 30, 2023 Hansa Biopharma AB โHansaโ (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release โฆSee details»
Hansa Biopharma is stepping up their portfolio and project โฆ
Nov 30, 2023 It will be exciting to follow Hansa Biopharma's progress as they develop and streamline their portfolio and project operations within their organization. Hansa is a โฆSee details»
Hansa Biopharma publishes Annual Report 2020
Lund, Sweden April 8, 2021 Hansa Biopharma AB โHansaโ (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the โฆSee details»
Genethon and Hansa Biopharma announce initiation of a Phase 2 โฆ
3 days ago The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the โฆSee details»
Jobs list - Hansa Biopharma
Hansa Biopharma and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics โฆSee details»
Hansa Biopharma Launches Phase 2 Trial for Gene Therapy โฆ
3 days ago Find out more at www.hansabiopharma.com and follow us on LinkedIn. About Genethon. A pioneer in the discovery and development of gene therapies for rare diseases, โฆSee details»
Hansa Biopharma AB certified as a Great Place to Work [® ]
Sep 11, 2020 Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work For Allโข. To learn more, visit โฆSee details»
Hansa Biopharma achieves Great Place to Work® certification for โฆ
Lund, Sweden, September 30, 2022. Hansa Biopharma AB, โHansaโ (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced its โฆSee details»